neutral
5h agoSun Pharma Stock Analysis: Price Hits ₹1,787.8 Amid Strong Market Interest
Sun Pharma's stock continues to show strong momentum, last traded at ₹1,787.8. The company’s market capitalization stands at ₹428,353.27 Cr, reflecting its prominent position in the market. With a volume of 507,172 shares traded, the stock maintains significant investor interest. Sun Pharma's price toearnings ratio is 40.99, while its earnings per share are ₹43.55.
Companies:
- Sun Pharma
Tags:
- Sun Pharma
- stock analysis
Explore:Mutual Fund Screening
neutral
5h agoSun Pharma Stock Analysis: Price Hits ₹1,787.8 Amid Strong Market Interest
Sun Pharma's stock continues to show strong momentum, last traded at ₹1,787.8. The company’s market capitalization stands at ₹428,353.27 Cr, reflecting its prominent position in the market. With a volume of 507,172 shares traded, the stock maintains significant investor interest. Sun Pharma's price toearnings ratio is 40.99, while its earnings per share are ₹43.55.
Companies:
- Sun Pharma
Tags:
- Sun Pharma
- stock analysis
Explore:Mutual Fund Screening
1 min read
54 words
Sun Pharma stock trades at ₹1,787.8 with a market cap of ₹428,353.27 Cr, showing stable performance and strong investor interest.
Sun Pharma's stock continues to show strong momentum, last traded at ₹1,787.8. The company’s market capitalization stands at ₹428,353.27 Cr, reflecting its prominent position in the market. With a volume of 507,172 shares traded, the stock maintains significant investor interest. Sun Pharma's price toearnings ratio is 40.99, while its earnings per share are ₹43.55.
Sun Pharma's stock continues to show strong momentum, last traded at ₹1,787.8. The company’s market capitalization stands at ₹428,353.27 Cr, reflecting its prominent position in the market. With a volume of 507,172 shares traded, the stock maintains significant investor interest. Sun Pharma's price toearnings ratio is 40.99, while its earnings per share are ₹43.55.
Companies:
- Sun Pharma
Tags:
- Sun Pharma
- stock analysis
- Sun Pharma
- stock analysis
- market updates
- pharmaceuticals
- P/E ratio
- earnings
Dec 3, 2025 • 06:35